Effect of gastrointestinal resection on sunitinib exposure in patients with GIST
Main Authors: | de Wit, Djoeke, van Erp, Nielka P, Khosravan, Reza, Wiltshire, Robin, Allred, Randy, Demetri, George D, Guchelaar, Henk-Jan, Gelderblom, Hans |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133599/ |
Similar Items
-
LAPAROSCOPIC RESECTION OF GASTROINTESTINAL STROMAL TUMORS (GIST)
by: LOUREIRO, Marcelo de Paula, et al.
Published: (2016) -
Gastrointestinal stromal tumors (GISTs) of the stomach: a multicenter, retrospective study of curatively resected gastric GISTs
by: Kim, In-Hwan, et al.
Published: (2014) -
Surgical resection for gastrointestinal stromal tumors (GIST): experience on 25 patients
by: Boni, Luigi, et al.
Published: (2005) -
The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study
by: Rutkowski, Piotr, et al.
Published: (2012) -
Evaluation of nilotinib in advanced GIST previously treated with imatinib and sunitinib
by: Cauchi, C., et al.
Published: (2011)